NOX signaling in molecular cardiovascular mechanisms involved in the blood pressure homeostasis

Frontiers in Physiology

Volumn 6, Issue JUL, 2015, Pages

  Santillo, Mariarosaria ^a   Colantuoni, Antonio ^a   Mondola, Paolo ^a   Guida, Bruna ^a   Damiano, Simona ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Ang II signaling; Blood pressure; Cardiomyocytes; Endothelial cells; NOX; Reactive oxygen species; Redox signaling; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; GKT 136901; GKT 137831; GKT 901; OXIDOREDUCTASE INHIBITOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; BLOOD VESSEL WALL; CARDIOVASCULAR SYSTEM; CELLULAR DISTRIBUTION; DRUG SELECTIVITY; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME STRUCTURE; HEART FIBROBLAST; HEART MUSCLE CELL; HUMAN; HYPERTENSION; INOTROPISM; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE CELL; VASODILATATION;

EID: 84940038503     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00194     Document Type: Short Survey

References (89)

1. + exchanger 1 gene expression connects intracellular redox status with cells sensitivity to death triggers. Cell Death Differ. 13, 628-641. doi: 10.1038/sj.cdd.4401775.
2. Babior, B. M., Lambeth, J. D., and Nauseef, W. (2002). The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397, 342-344. doi: 10.1006/abbi.2001.2642.
3. Bae, Y. S., Choi, M. K., and Lee, W. J. (2010). Dual oxidase in mucosal immunity and host-microbe homeostasis. Trends Immunol. 31, 278-287. doi: 10.1016/j.it.2010.05.003.
4. Barbacanne, M. A., Souchard, J. P., Darblade, B., Liou, J. P., Nepveu, F., Ppy, B., et al. (2000). Detection of superoxide anion realeased extracellularly by endothelial cells using cytochrome c reduction, ESR, fluorescence and lucigenin-enhanced chemiluminescence technique. Free Radic. Biol. Med. 29, 388-396. doi: 10.1016/S0891-5849(00)00336-1.
5. Baroni, S. S., Santillo, M., Bevilacqua, F., Luchetti, M., Spadoni, T., Mancini, M., et al. (2006). Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N. Eng. J. Med. 354, 2667-2676. doi: 10.1056/NEJMoa052955.
6. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., and Freeman, B. A. (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87, 1620-1624. doi: 10.1073/pnas.87.4.1620.
7. Bedard, K., and Krause, K. H. (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245-313. doi: 10.1152/physrev.00044.2005.
8. Berry, C., Hamilton, C. A., Brosnan, M. J., Magill, F. G., Berg, G. A., McMurray, J. J. V., et al. (2000). Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101, 2206-2212. doi: 10.1161/01.CIR.101.18.2206.
9. Bertoni, A., Giuliano, P., Galgani, M., Rotoli, D., Ulianich, L., Adornetto, A., et al. (2011). Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins. J. Biol. Chem. 286, 4727-4741. doi: 10.1074/jbc.M110.156521.
10. Brown, D. I., and Griendling, K. K. (2009). Nox proteins in signal transduction. Free Radic. Biol. Med. 47, 1239-1253. doi: 10.1016/j.freeradbiomed.2009.07.023.
11. Byrne, J. A., Grieve, D. J., Bendall, J. K., Li, J. M., Gove, C., Lambeth, J. D., et al. (2003). Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 93, 802-805. doi: 10.1161/01.RES.0000099504.30207.F5.
12. Cai, H., Griendling, K. K., and Harrison, D. G. (2003). The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24, 471-478. doi: 10.1016/S0165-6147(03)00233-5.
13. Cassano, S., Agnese, S., D'amato, V., Papale, M., Garbi, C., Castagnola, P., et al. (2010). ROS, Ki-Ras and mitochondrial SOD co-operate in NGF-induced differentiation of PC12 cells. J. Biol. Chem. 285, 24141-24153. doi: 10.1074/jbc.M109.098525.
14. Chan, E. C., Jiang, F., Peshavariya, H. M., and Dusting, G. J. (2009). Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering. Pharmacol. Ther. 122, 97-108. doi: 10.1016/j.pharmthera.2009.02.005.
15. Cruzado, M. C., Risler, N. R., Miatello, R. M., Yao, G., Schiffrin, E. L., and Touyz, R. M. (2005). Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. Am. J. Hypertens. 18, 81-87. doi: 10.1016/j.amjhyper.2004.09.001.
16. Csányi, G., Cifuentes-Pagano, E., Al Ghouleh, I., Ranayhossaini, D. J., Egaña, L., Lopes, L. R., et al. (2011). Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2. Free Radic. Biol. Med. 51, 1116-1125. doi: 10.1016/j.freeradbiomed.2011.04.025.
17. Cuda, G., Paternò, R., Ceravolo, R., Candigliota, M., Pernotti, N., Perticone, F., et al. (2002). Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation 105, 968-974. doi: 10.1161/hc0802.104324.
18. Damiano, S., Fusco, R., Morano, A., De Mizio, M., Paternò, R., De Rosa, A., et al. (2012). Reactive oxygen species regulate the levels of dual oxidase (duox1-2) in human neuroblastoma cells. PLoS ONE 7:e34405. doi: 10.1371/journal.pone.0034405.
19. Damiano, S., Morano, A., Ucci, V., Accetta, R., Mondola, P., Paternò, R., et al. (2015). Dual oxidase 2 generated reactive oxygen species selectively mediate the induction of mucins by epidermal growth factor in enterocytes. Int. J. Biochem. Cell Biol. 60C, 8-18. doi: 10.1016/j.biocel.2014.12.014.
20. Damiano, S., Petrozziello, T., Ucci, V., Amente, S., Santillo, M., and Mondola, P. (2013). Cu-Zn superoxide dismutase activates muscarinic acetylcholine M1 receptor pathway in neuroblastoma cells. Mol. Cell. Neurosci. 52, 31-37. doi: 10.1016/j.mcn.2012.11.001.
21. Damico, R., Zulueta, J. J., and Hassoun, P. M. (2012). Pulmonary endothelial cell NOX. Am. J. Respir. Cell Mol. Biol. 47, 129-139. doi: 10.1165/rcmb.2010-0331RT.
22. De Deken, X., Wang, D., Many, M. C., Costagliola, S., Libert, F., Vassart, G., et al. (2000). Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 275, 23227-23233. doi: 10.1074/jbc.M000916200.
23. der Vliet, A. (2008). NADPH oxidases in lung biology and pathology: host defence enzymes, and more. Free Radical. Biol. Med. 44, 938-955. doi: 10.1016/j.freeradbiomed.2007.11.016.
24. Dikalova, A. E., Go'ngora, M. C., Harrison, D. G., Lambeth, J. D., Dikalov, S., and Griendling, K. K. (2010). Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium dependent relaxation via eNOS uncoupling. Am. J. Physiol. Heart Circ. Physiol. 299, H673-H679. doi: 10.1152/ajpheart.00242.2010.
25. Dinauer, M. C., Orkin, S. H., Brown, R., Jesaitis, A. J., and Parkos, C. A. (1987). The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 327, 717-720. doi: 10.1038/327717a0.
26. Donko, A., Péterfi, Z., Sum, A., Leto, T., and Geiszt, M. (2005). Dual oxidases. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360, 2301-2308. doi: 10.1098/rstb.2005.1767.
27. Gabrielli, A., Svegliati, S., Moroncini, G., Pomponio, G., Santillo, M., and Avvedimento, E. V. (2008). Oxidative stress and the pathogenesis of scleroderma: the murrell's hypothesis revisited. Semin. Immunopathol. 30, 329-337. doi: 10.1007/s00281-008-0125-4.
28. Ghiadoni, L., Virdis, A., Magagna, A., Taddei, S., and Salvetti, A. (2000). Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension 35, 501-506. doi: 10.1161/01.HYP.35.1.501.
29. Görlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F., and Busse, R. (2000). A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87, 26-32. doi: 10.1161/01.RES.87.1.26.
30. Harper, R. W., Xu, C., Eiserich, J. P., Chen, Y., Kao, C. Y., Thai, P., et al. (2005). Differential regulation of dual NADPH oxidases/peroxidases, Duox1 and Duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett. 579, 4911-4917. doi: 10.1016/j.febslet.2005.08.002.
31. Hilenski, L. L., Clempus, R. E., Quinn, M. T., Lambeth, J. D., and Griendling, K. K. (2004). Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24, 677-683. doi: 10.1161/01.ATV.0000112024.13727.2c.
32. Hornig, B., Landmesser, U., Kohler, C., Ahlersmann, D., Spiekermann, S., Christoph, A., et al. (2001). Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 103, 799-805. doi: 10.1161/01.CIR.103.6.799.
33. Ito, H., Hirata, Y., Adachi, S., Tanaka, M., Tsujino, M., Koike, A., et al. (1993). Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 92, 398-403. doi: 10.1172/JCI116579.
34. Jay, D. B., Papaharalambus, C. A., Seidel-Rogol, B., Dikalova, A. E., Lassegue, B., and Griendling, K. K. (2008). Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radic. Biol. Med. 45, 329-335. doi: 10.1016/j.freeradbiomed.2008.04.024.
35. Jones, S. A., O'Donnell, V. B., Wood, J. D., Broughton, J. P., Hughes, E. J., and Jones, O. T. (1996). Expression of phagocyte NADPH oxidase components in human endothelial cells. Am. J. Physiol. 271, 1626-1634.
36. Kim, M., Han, C. H., and Lee, M. Y. (2014). NADPH oxidase and the cardiovascular toxicity associated with smoking. Toxicol. Res. 30, 149-157. doi: 10.5487/TR.2014.30.3.149.
37. Knaus, U. G., Heyworth, P. G., Evans, T., Curnutte, J. T., and Bokoch, G. M. (1991). Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 254, 1512-1515. doi: 10.1126/science.1660188.
38. Lambeth, J. D. (2004). NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181-189. doi: 10.1038/nri1312.
39. Landmesser, U., Cai, H., Dikalov, S., McCann, L., Hwang, J., Jo, H., et al. (2002). Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40, 511-515. doi: 10.1161/01.HYP.0000032100.23772.98.
40. Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., et al. (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 111, 1201-1209. doi: 10.1172/JCI200314172.
41. Lassegue, B., and Clempus, R. E. (2003). Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R277-R297. doi: 10.1152/ajpregu.00758.2002.
42. Lassègue, B., San Martín, A., and Griendling, K. K. (2012). Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 110, 1364-1390. doi: 10.1161/CIRCRESAHA.111.243972.
43. Lee, M. Y., and Griendling, K. K. (2008). Redox signaling, vascular function, and hypertension. Antioxid. Redox Signal. 10, 1045-1059. doi: 10.1089/ars.2007.1986.
44. Li, J. M., and Shah, A. M. (2002). Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J. Biol. Chem. 277, 19952-19960. doi: 10.1074/jbc.M110073200.
45. Li, Y., Le'vesque, L. O., and Anand-Srivastava, M. B. (2010). Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. Am. J. Physiol. Heart Circ. Physiol. 299, H1959-H1967. doi: 10.1152/ajpheart.00526.2010.
46. Martin, K. D., Frederick, L. M., von Loehneysen, K., Dinauer, M. C., and Knaus, U. G. (2006). Functional analysis of nox4 reveals unique characteristics compared to other NADPH oxidases. Cell. Signal. 18, 69-82. doi: 10.1016/j.cellsig.2005.03.023.
47. McNally, J. S., Davis, M. E., Giddens, D. P., Saha, A., Hwang, J., Dikalov, S., et al. (2003). Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol. Heart Circ. Physiol. 285, H2290-H22977. doi: 10.1152/ajpheart.00515.2003.
48. Mehta, P. K., and Griendling, K. K. (2007). Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 292, C82-C97. doi: 10.1152/ajpcell.00287.2006.
49. Mondola, P., Santillo, M., Serù, R., Damiano, S., Alvino, C., Ruggiero, G., et al. (2004). Cu, Zn superoxide dismutase increases intracellular calcium levels via a phospholipase C-protein kinase C pathway in SK-N-BE neuroblastoma cells. Biochem. Biophys. Res. Commun. 324, 887-892. doi: 10.1016/j.bbrc.2004.09.131.
50. Montezano, A. C., Nguyen Dinh Cat, A., Rios, F. J., and Touyz, R. M. (2014). Angiotensin II and vascular injury. Curr. Hypertens. Rep. 16, 431. doi: 10.1007/s11906-014-0431-2.
51. Murdoch, C. E., Alom-Ruiz, S. P., Wang, M., Zhang, M., Walker, S., Yu, B., et al. (2011). Role of endothelial NOX2-NADPHoxidase in angiotensin II-induced hypertension and vasomotor dysfunction. Basic Res. Cardiol. 106, 527-538. doi: 10.1007/s00395-011-0179-7.
52. Murray, T. V., Smyrnias, I., Shah, A. M., and Brewer, A. C. (2013). NADPH oxidase 4 regulates cardiomyocyte differentiation via redox activation of c-Jun protein and the cis-regulation of GATA-4 gene transcription. J. Biol. Chem. 288, 15745-15759. doi: 10.1074/jbc.M112.439844.
53. Nguyen Dinh Cat, A., Montezano, A. C., Burger, D., and Touyz, R. M. (2013). Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid. Redox Signal. 19, 1110-1120. doi: 10.1089/ars.2012.4641.
54. Nishida, M., Kitajima, N., Saiki, S., Nakaya, M., and Kurose, H. (2011). Regulation of angiotensin II receptor signaling by cysteine modification of NF-jB. Nitric Oxide 25, 112-117. doi: 10.1016/j.niox.2010.10.003.
55. Opie, L. H. (2004). Heart Physiology. From Cell to Circulation. 4th Edn. Philadelphia: Lippincott Williams and Wilkins.
56. Petry, A., Weitnauer, M., and Görlach, A. (2010). Receptor activation of NADPH oxidases. Antioxid. Redox Signal. 13, 467-487. doi: 10.1089/ars.2009.3026.
57. Prosser, B. L., Ward, C. W., and Lederer, W. J. (2011). X-ROS signaling: rapid mechano-chemo transduction in heart. Science 333, 1440-1445. doi: 10.1126/science.1202768.
58. Prosser, B. L., Ward, C. W., and Lederer, W. J. (2013). X-ROS signalling is enhanced and graded by cyclic cardiomyocyte stretch. Cardiovasc. Res. 98, 307-314. doi: 10.1093/cvr/cvt066.
59. Ranayhossaini, D. J., Rodriguez, A. I., Sahoo, S., Chen, B. B., Mallampalli, R. K., Kelley, E. E., et al. (2013). Selective recapitulation of conserved and non conserved regions of putative NOXA1 protein activation domain confers isoform-specific inhibition of Nox1 oxidase and attenuation of endothelial cell migration. J. Biol. Chem. 288, 36437-36450. doi: 10.1074/jbc.M113.521344.
60. Raven, P. B., and Chapleau, M. W. (2014). Blood pressure regulation XI: overview and future research directions Eur. J. Appl. Physiol. 114, 579-586. doi: 10.1007/s00421-014-2823-z.
61. Ray, R., Murdoch, C. E., Wang, M., Santos, C. X., Zhang, M., Alom-Ruiz, S., et al. (2011). Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler. Thromb. Vasc. Biol. 31, 1368-1376. doi: 10.1161/ATVBAHA.110.219238.
62. Ris-Stalpers, C. (2006). Physiology and pathophysiology of the DUOXes. Antioxid. Redox Signal. 8, 1563-1572. doi: 10.1089/ars.2006.8.1563.
63. Ruocco, A., Santillo, M., Cicale, M., Serù, R., Cuda, G., Anrather, J., et al. (2007). Farnesyl transferase inhibitors induce neuroprotection by inhibiting Ha-Ras signalling pathway. Eur. J. Neurosci. 26, 3261-3266. doi: 10.1111/j.1460-9568.2007.05935.x.
64. Russo, M., Cocco, S., Secondo, A., Adornetto, A., Bassi, A., Nunziata, A., et al. (2011). Cigarette smoke condensate causes a decrease of the gene expression of Cu-Zn superoxide dismutase, Mn superoxide dismutase, glutathione peroxidase, catalase, and free radical-induced cell injury in SH-SY5Y human neuroblastoma cells. Neurotox. Res. 19, 49-54. doi: 10.1007/s12640-009-9138-6.
65. Sabbatini, M., Santillo, M., Pisani, A., Paternò, R., Uccello, F., Serù, R., et al. (2006). Inhibition of Ras/ERK1/2 signaling protects against postischemic renal injury. Am. J. Physiol. Renal Physiol. 290, F1408-F1415. doi: 10.1152/ajprenal.00304.2005.
66. Sadoshima, J., Xu, Y., Slayter, H. S., and Izumo, S. (1993). Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75, 977-984. doi: 10.1016/0092-8674(93)90541-W.
67. Sag, C. M., Wagner, S., and Maier, L. S. (2013). Role of oxidants on calcium and sodium movement in healthy and diseased cardiacmyocytes. Free Radical. Biol. Med. 63, 338-349. doi: 10.1016/j.freeradbiomed.2013.05.035.
68. Santillo, M., Mondola, P., Serù, R., Annella, T., Cassano, S., Ciullo, I., et al. (2001). Opposing functions of Ki-and Ha-Ras genes in the regulation of redox signals. Curr. Biol. 11, 614-619. doi: 10.1016/S0960-9822(01)00159-2.
69. Santillo, M., Secondo, A., Serù, R., Damiano, S., Garbi, C., Taverna, E., et al. (2007). Evidence of calcium-and SNARE-dependent release of CuZn superoxide dismutase from rat pituitary GH3 cells and synaptosomes in response to depolarization. J. Neurochem. 102, 679-685. doi: 10.1111/j.1471-4159.2007.04538.x.
70. Schieber, M., and Chandel, N. S. (2014). ROS function in redox signaling and oxidative stress. Curr. Biol. 24, R453-R462. doi: 10.1016/j.cub.2014.03.034.
71. Schröder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., et al. (2012). NOX4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ. Res. 110, 1217-1225. doi: 10.1161/CIRCRESAHA.112.267054.
72. Secondo, A., De Mizio, M., Zirpoli, L., Santillo, M., and Mondola, P. (2008). The Cu-Zn superoxide dismutase (SOD1) inhibits ERK phosphorylation by muscarinic receptor modulation in rat pituitary GH3 cells. Biochem. Biophys. Res. Commun. 376, 143-147. doi: 10.1016/j.bbrc.2008.08.110.
73. Segal, A. W., and Jones, O. T. (1978). Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature 276, 515-517. doi: 10.1038/276515a0.
74. Seru, R., Mondola, P., Damiano, S., Svegliati, S., Agnese, S., Avvedimento, E. V., et al. (2004). HaRas activates the NADPH oxidase complex in human neuroblastoma cells via extracellular signal-regulated kinase 1/2 pathway. J. Neurochem. 91, 613-622. doi: 10.1111/j.1471-4159.2004.02754.x.
75. Sies, H. (1991). Oxidative stress: from basic research to clinical application. Am. J. Med. 91, 31S-38S. doi: 10.1016/0002-9343(91)90281-2.
76. Sirker, A., Zhang, M., and Shah, A. M. (2011). NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies. Basic Res. Cardiol. 106, 735-747. doi: 10.1007/s00395-011-0190-z.
77. Sorescu, D., Weiss, D., Lassègue, B., Clempus, R. E., Szöcs, K., Sorescu, G. P., et al. (2002). Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105, 1429-1435. doi: 10.1161/01.CIR.0000012917.74432.66.
78. Svegliati, S., Cancello, R., Sambo, P., Luchetti, M., Paroncini, P., Orlandini, G., et al. (2005). PDGF and reactive oxygen species (ROS) regulate ras protein levels in primary human fibroblasts via ERK1/2: amplification of ROS and ras in systemic sclerosis fibroblasts. J. Biol. Chem. 280, 36474-36482. doi: 10.1074/jbc.M502851200.
79. Takac, I., Schröder, K., and Brandes, R. P. (2012). The nox family of NADPH oxidases: friend or foe of the vascular system? Curr. Hypertens. Rep. 14, 70-78. doi: 10.1007/s11906-011-0238-3.
80. Terrazzano, G., Rubino, V., Damiano, S., Sasso, A., Petrozziello, T., Ucci, V., et al. (2014). T cell activation induces CuZn superoxide dismutase (SOD)-1 intracellular re-localization, production and secretion. Biochim. Biophys. Acta. 1843, 265-274. doi: 10.1016/j.bbamcr.2013.10.020.
81. Touyz, R. M., and Schiffrin, E. L. (2000). Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 52, 639-672.
82. Touyz, R. M., Yao, G., Quinn, M. T., Pagano, P. J., and Schiffrin, E. L. (2005). p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 25, 512-518. doi: 10.1161/01.ATV.0000154141.66879.98.
83. Virdis, A., Neves, M. F., Amiri, F., Touyz, R. M., and Schiffrin, E. L. (2004). Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J. Hypertens. 22, 535-542. doi: 10.1097/00004872-200403000-00016.
84. Wang, H. D., Xu, S., Johns, D. G., Du, Y., Quinn, M. T., Cayatte, A. J., et al. (2001). Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ. Res. 88, 947-953. doi: 10.1161/hh0901.089987.
85. Weng, X., Yu, L., Liang, P., Li, L., Dai, X., Zhou, B., et al. (2015). A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 82, 48-58. doi: 10.1016/j.yjmcc.2015.02.010.
86. Yada, T., Shimokawa, H., Hiramatsu, O., Kajita, T., Shigeto, F., Goto, M., et al. (2003). Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 107, 1040-1045. doi: 10.1161/01.CIR.0000050145.25589.65.
87. Zalba, G., San José, G., Moreno, U. M., Fortuno, A., and Diez, J. (2005). NADPH oxidase-mediated oxidative stress: genetic studies of the p22phox gene in hypertension Antioxid. Redox Signal. 7, 1327-1336. doi: 10.1089/ars.2005.7.1327.
88. Zhang, M., Brewer, A. C., Schröder, K., Santos, C. X., Grieve, D. J., Wang, M., et al. (2010). NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 18121-18126. doi: 10.1073/pnas.1009700107.
89. Zhang, Q., Malik, P., Pandey, D., Gupta, S., Jagnandan, D., Belin de Chantemele, E., et al. (2008). Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase. Arterioscler. Thromb. Vasc. Biol. 28, 1627-1633. doi: 10.1161/ATVBAHA.108.168278.